These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Lu KH; Wu W; Dave B; Slomovitz BM; Burke TW; Munsell MF; Broaddus RR; Walker CL Clin Cancer Res; 2008 May; 14(9):2543-50. PubMed ID: 18451215 [TBL] [Abstract][Full Text] [Related]
4. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma. Marsh J; Mukherjee P; Seyfried TN Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102 [TBL] [Abstract][Full Text] [Related]
5. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Yang Q; Inoki K; Kim E; Guan KL Proc Natl Acad Sci U S A; 2006 May; 103(18):6811-6. PubMed ID: 16627617 [TBL] [Abstract][Full Text] [Related]
6. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα). Dan HC; Ebbs A; Pasparakis M; Van Dyke T; Basseres DS; Baldwin AS J Biol Chem; 2014 Sep; 289(36):25227-40. PubMed ID: 24990947 [TBL] [Abstract][Full Text] [Related]
7. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition. Bhaskar PT; Nogueira V; Patra KC; Jeon SM; Park Y; Robey RB; Hay N Mol Cell Biol; 2009 Sep; 29(18):5136-47. PubMed ID: 19620286 [TBL] [Abstract][Full Text] [Related]
8. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. Yuan M; Pino E; Wu L; Kacergis M; Soukas AA J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877 [TBL] [Abstract][Full Text] [Related]
9. Renal tumours in a Tsc2(+/-) mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Yang J; Kalogerou M; Samsel PA; Zhang Y; Griffiths DF; Gallacher J; Sampson JR; Shen MH Oncogene; 2015 Feb; 34(7):922-31. PubMed ID: 24632604 [TBL] [Abstract][Full Text] [Related]
10. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Jacinto E; Facchinetti V; Liu D; Soto N; Wei S; Jung SY; Huang Q; Qin J; Su B Cell; 2006 Oct; 127(1):125-37. PubMed ID: 16962653 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex. Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214 [TBL] [Abstract][Full Text] [Related]
17. Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway. Ma Z; Qi J; Meng S; Wen B; Zhang J Eur J Appl Physiol; 2013 Oct; 113(10):2473-86. PubMed ID: 23812090 [TBL] [Abstract][Full Text] [Related]
18. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285 [TBL] [Abstract][Full Text] [Related]
19. Differential IKK/NF-κB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells. Gao Y; Gartenhaus RB; Lapidus RG; Hussain A; Zhang Y; Wang X; Dan HC Mol Cancer Res; 2015 Dec; 13(12):1602-14. PubMed ID: 26374334 [TBL] [Abstract][Full Text] [Related]